Discovery MI

The GE Discovery™ MI Gen 2 PET/CT system represents a significant advancement in molecular imaging, offering unparalleled sensitivity, precision, and efficiency for comprehensive oncology, cardiology, and neurology diagnostics. Building upon the foundation of its predecessor, the Discovery MI, the Gen 2 model introduces cutting-edge technologies to enhance clinical outcomes and streamline workflows.
Key Features
Enhanced Sensitivity and Coverage
Equipped with the LightBurst Digital Detector, the Discovery MI Gen 2 achieves an impressive axial field of view (FOV) of up to 30 centimeters, providing a 50% increase in peak noise-equivalent count rate (NECR). This expansion enables faster scan times and improved lesion detectability, particularly for small lesions.
Whole-Body Dynamic Imaging
The system introduces the Whole-Body Dynamic IQ protocol, allowing for dynamic PET imaging across the entire body in a single acquisition. This approach enhances the assessment of tracer kinetics, aiding in the differentiation between benign and malignant lesions and improving the accuracy of disease staging.
Advanced Motion Correction
MotionFree, a proprietary motion correction technology, eliminates the need for external gating devices by compensating for respiratory motion during imaging. This innovation results in clearer images and more accurate quantification, particularly beneficial for patients who are unable to hold their breath during scans.
TrueFidelity CT Imaging
Integrated with the Revolution EVO Gen 3 CT, the Discovery MI Gen 2 utilizes TrueFidelity, a deep-learning-based image reconstruction technology. This system delivers high-quality CT images with improved texture and reduced noise, facilitating precise anatomical localization and enhancing the overall diagnostic experience.
Quantitative Accuracy with Q.Clear
The Q.Clear (BSREM) algorithm provides up to a twofold improvement in both PET quantitation accuracy (SUVmean) and image quality (signal-to-noise ratio), ensuring reliable and reproducible measurements essential for treatment planning and monitoring.
User-Centric Workflow Enhancements
AutoIN enables remote patient positioning and landmarking from the console, reducing radiation exposure and minimizing contact with patients. This feature enhances workflow efficiency and supports infection control protocols.
Applications
The Discovery MI Gen 2 is designed to support a wide range of clinical applications, including:
Oncology: Accurate tumor detection, staging, and monitoring of treatment response.
Cardiology: Assessment of myocardial viability and perfusion.
Neurology: Evaluation of neurodegenerative diseases and brain function.
Theranostics: Personalized treatment planning using radiopharmaceuticals.
Conclusion
The GE Discovery MI Gen 2 PET/CT system sets a new standard in molecular imaging, combining advanced technologies to provide exceptional image quality, enhanced sensitivity, and streamlined workflows. Its capabilities support clinicians in delivering precise and personalized care, ultimately improving patient outcomes across various medical disciplines.

The GE Discovery™ MI Gen 2 PET/CT system offers advanced sensitivity, precision, and efficiency for oncology, cardiology, and neurology diagnostics. With features like enhanced motion correction, whole-body dynamic imaging, and TrueFidelity CT imaging, it delivers high-quality, accurate results. The system’s user-friendly design and innovative technologies support faster workflows and improved patient care, making it a powerful tool for personalized treatment planning and monitoring.